文献速递心脑血管急症重症综合管理与镇静镇痛

重症成人新发心房颤动与相关结局及资源使用:多中心回顾性队列研究

New-onset atrial fibrillation and associated outcomes and resource use among critically ill adults-a multicenter retrospective cohort study.
PubMed 文献 · Crit Care · 2020-01-13
一句话结论重症成人新发心房颤动总体不增加住院死亡几率,但与脓毒症共存时住院死亡几率升高,且与ICU住院时间延长和总费用增加相关。

该多中心回顾性队列研究纳入加拿大两家医院2011—2016年连续收治的≥18岁ICU患者,排除入院前已知心房颤动病史者,共15014例,其中1541例(10.3%)在ICU期间发生新发心房颤动。新发心房颤动与全队列住院死亡几率无显著关联(校正比值比1.02,95%CI 0.97-1.08),但与脓毒症存在交互作用,两者共存时住院死亡几率高于任一单独存在(校正比值比1.28,95%CI 1.09-1.36)。新发心房颤动患者总费用更高(费用比1.09,95%CI 1.02-1.20),在新发心房颤动患者中采用节律控制策略与更高费用相关(费用比1.24,95%CI 1.07-1.40)。

要点

  • 重症成人新发心房颤动发生率为10.3%(1541/15014),全队列中与住院死亡几率无显著关联(校正比值比1.02,95%CI 0.97-1.08)。
  • 新发心房颤动与脓毒症共存时住院死亡几率高于任一单独存在(校正比值比1.28,95%CI 1.09-1.36)。
  • 新发心房颤动患者总费用更高(费用比1.09,95%CI 1.02-1.20)。
  • 在新发心房颤动患者中,节律控制策略与更高费用相关(费用比1.24,95%CI 1.07-1.40)。
  • 新发心房颤动与ICU住院时间延长相关。

适用人群与场景

  • 加拿大两家医院2011—2016年连续收治的≥18岁ICU患者。
  • 排除入院前已知心房颤动病史的患者。

研究设计与关键结果

  • 研究类型为多中心回顾性队列研究,纳入15014例ICU患者,其中1541例(10.3%)发生新发心房颤动。
  • 主要终点住院死亡:新发心房颤动与住院死亡几率无显著关联(校正比值比1.02,95%CI 0.97-1.08)。
  • 新发心房颤动与脓毒症存在交互作用,两者共存时住院死亡几率高于任一单独存在(校正比值比1.28,95%CI 1.09-1.36)。
  • 新发心房颤动患者总费用更高(费用比1.09,95%CI 1.02-1.20)。
  • 在新发心房颤动患者中,节律控制策略与更高费用相关(费用比1.24,95%CI 1.07-1.40)。
  • 新发心房颤动与ICU住院时间延长相关。

证据类型、等级与局限

  • 证据类型:多中心回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 重症成人出现新发心房颤动时,应关注是否合并脓毒症,两者共存与住院死亡几率升高相关(校正比值比1.28,95%CI 1.09-1.36)。
  • 新发心房颤动与ICU住院时间延长和总费用增加相关,资源规划时需考虑。
  • 在新发心房颤动患者中,节律控制策略与更高费用相关(费用比1.24,95%CI 1.07-1.40)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: New-onset atrial fibrillation (NOAF) is commonly encountered in critically ill adults. Evidence evaluating the association between NOAF and patient-important outcomes in this population is conflicting. Furthermore, little is known regarding the association between NOAF and resource use or hospital costs.

METHODS: Retrospective analysis (2011-2016) of a prospectively collected registry from two Canadian hospitals of consecutive ICU patients aged ≥ 18 years. We excluded patients with a known history of AF prior to hospital admission. Any occurrence of atrial fibrillation (AF) was prospectively recorded by bedside nurses. The primary outcome was hospital mortality, and we used multivariable logistic regression to adjust for confounders. We used a generalized linear model to evaluate contributors to total cost.

RESULTS: We included 15,014 patients, and 1541 (10.3%) had NOAF during their ICU admission. While NOAF was not associated with increased odds of hospital death among the entire cohort (adjusted odds ratio [aOR] 1.02 [95% confidence interval [CI] 0.97-1.08]), an interaction was noted between NOAF and sepsis, and the presence of both was associated with higher odds of hospital mortality (aOR 1.28 [95% CI 1.09-1.36]) than either alone. Patients with NOAF had higher total costs (cost ratio [CR] 1.09 [95% CI 1.02-1.20]). Among patients with NOAF, treatment with a rhythm-control strategy was associated with higher costs (CR 1.24 [95% CI 1.07-1.40]).

CONCLUSIONS: While NOAF was not associated with death or requiring discharge to long-term care among critically ill patients, it was associated with increased length of stay in ICU and increased total costs.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Fernando SM, Mathew R, Hibbert B, et al. New-onset atrial fibrillation and associated outcomes and resource use among critically ill adults-a multicenter retrospective cohort study. Crit Care. 2020. PMID: 31931845. doi:10.1186/s13054-020-2730-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。